Pulmatrix Statistics
NASDAQ: PULMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.53+0.0371 (+2.49%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pulmatrix by the numbers
Pulmatrix has a market capitalization of $5.6 million based on 3.65M shares outstanding. With trailing EPS of $-1.10, Pulmatrix is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.2% below its 50-day average and 14.4% below its 200-day average.
Average daily trading volume is 24.75K shares, or about $37,800 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PULM valuation vs. peer median
| Metric | PULM | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.58M | $5.48M | +2% |
| Avg. volume | 24.75K | 574.13K | -96% |
Peer median across 8 companies: BGMS, ENLV, ADXN, DRMA, KALA, RDHL, LNAI, GELS.
Valuation
- Market cap
- $5.58M
- EPS (TTM)
- $-1.10
- Shares outstanding
- 3.65M
Price and trading
- Previous close
- 1.49
- Open
- 1.48
- Day range
- 1.42 – 1.58
- 52-week range
- 1.16 – 5.24
- Beta
- —
- Volume
- 13.07K
- Average volume
- 24.75K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 15, 2026
Additional statistics
- Market Cap
- 5.58M
- Forward Pe
- -0.34
- Eps
- -1.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.24
- Week52 Low
- 1.16
- Avg Volume
- 24,753.00
- Shares Outstanding
- 3.65M
- Ma50
- 1.55
- Ma200
- 1.78
- Earnings Date
- Oct 15, 2026
- Pct From52w High
- -70.83%
- Pct From52w Low
- 31.65%